Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection

OBJECTIVES: To evaluate the pharmacokinetics and clinical effectiveness of IV and oral fosfomycin treatment in patients with recurrent urinary tract infection (rUTI) with Escherichia coli. PATIENTS AND METHODS: Patients with rUTI treated with 3 g of oral fosfomycin every 72 h for at least 14 days we...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuiper, Sander G, Dijkmans, Anneke C, Wilms, Erik B, Kamerling, Ingrid M C, Burggraaf, Jacobus, Stevens, Jasper, van Nieuwkoop, Cees
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297308/
https://www.ncbi.nlm.nih.gov/pubmed/32712666
http://dx.doi.org/10.1093/jac/dkaa294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297308/
https://www.ncbi.nlm.nih.gov/pubmed/32712666
http://dx.doi.org/10.1093/jac/dkaa294

Ejemplares similares